MAP4K4-IN-6
MAP4K4-IN-6 (Compound 15f) is a MAP4K4 inhibitor (IC50: 80 nM) . MAP4K4-IN-6 reduces the c-Jun phosphorylation. MAP4K4-IN-6 has neuroprotective effects. MAP4K4-IN-6 increases the viability of motor neurons. MAP4K4-IN-6 can be used for research of Amyotrophic lateral sclerosis (ALS) [1].
Product Specifications
UNSPSC
12352211
Target
JNK; MAP4K
Type
Reference compound
Related Pathways
MAPK/ERK Pathway
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/map4k4-in-6.html
Smiles
O=C(NC)C(S1)=C(NC(N)=O)C=C1C2=CC=C(C(F)(F)F)C=C2
Molecular Formula
C14H12F3N3O2S
Molecular Weight
343.32
References & Citations
[1]Hattori H, et al. Discovery of 5-phenyl-3-ureidothiophene-2-carboxamides as protective agents for ALS patient iPSC-derived motor neur
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
41159121 3x 1.0µg DNA
RPL23AP35 CRISPRa sgRNA lentivector (set of three targets)(Human)
Ask
View Details 
034991-PE 200 µL
EIF2B1, ID (EIF2B1, EIF2BA, Translation initiation factor eIF-2B subunit alpha, eIF-2B GDP-GTP exchange factor subunit alpha) (PE) discontinued
Ask
View Details MBS6458083-01 0.1 mL
PDGFD (Platelet-Derived Growth Factor D, PDGF-D, Iris-Expressed Growth Factor, Spinal cord-Derived Growth Factor B, SCDGF-B, Platelet-Derived Growth Factor D, latent form, PDGFD Latent form, Platelet-Derived Growth Factor D, Receptor-Binding form, PDGFD R
Ask
View Details MBS6458083-02 5x 0.1 mL
PDGFD (Platelet-Derived Growth Factor D, PDGF-D, Iris-Expressed Growth Factor, Spinal cord-Derived Growth Factor B, SCDGF-B, Platelet-Derived Growth Factor D, latent form, PDGFD Latent form, Platelet-Derived Growth Factor D, Receptor-Binding form, PDGFD R
Ask
View Details